An evaluation of tranquillisers for use with etorphine as neuroleptanalgesic agents in the horse.
D000075:Acepromazine / Q000494:pharmacology; D000818:Animals; D001376:Azaperone / Q000008:administration & dosage* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002090:Butyrophenones / Q000008:administration & dosage*; D002339:Carotid Arteries / Q000502:physiology; D005048:Etorphine / Q000008:administration & dosage* / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006736:Horses / Q000502:physiology*; D009019:Morphinans / Q000008:administration & dosage*; D009458:Neuroleptanalgesia / Q000379:methods / Q000662:veterinary*; D013843:Thiazines / Q000008:administration & dosage*; D014991:Xylazine / Q000008:administration & dosage* / Q000494:pharmacology
D002090:Butyrophenones; D009019:Morphinans; D013843:Thiazines; D001376:Azaperone; D014991:Xylazine; D005048:Etorphine; D000075:Acepromazine